Skip to the content
Kure Cellslogo darklogo light
  • Home
  • About Us
  • Technology
  • Pipeline
  • News
  • Partner With Us
Kure Cells
  • Home
  • About Us
  • Technology
  • Pipeline
  • News
  • Partner With Us
HomeKureCellsISCT Top Scoring Abstract Award for UF-Kure19 Ph1 trial
KureCells

ISCT Top Scoring Abstract Award for UF-Kure19 Ph1 trial

rkjamvi@gmail.com
May 17, 2025
KureCells
Share share
  • .face-icon{fill:#fff;}
  • .tw-icon{fill:#fff;}
  • .ln-icon{fill:#fff;}
  • .pn-icon{fill:#fff;}
Previous post
ASH Annual Meeting Oral Presentation on UF-Kure19
Next post
NCI $2.2 M Grant to support Phase 2 UF-Kure19 trial

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related articles

w
w
KureCells
Kure Cells closed pre-Series A funding round led by Waed Ventures (Aramco) alongside NantBio, US93 and Qomel
rkjamvi@gmail.com
October 23, 2025
w
KureCells
ASH Annual Meeting Oral Presentation on UF-Kure19
rkjamvi@gmail.com
December 8, 2024
w
https://marity.qodeinteractive.com/wp-content/uploads/2022/11/Josh-Woodward-Gravity-1.mp3
KureCells
NCI $2.2 M Grant to support Phase 2 UF-Kure19 trial
rkjamvi@gmail.com
August 8, 2025
rkjamvi@gmail.com

principal scientist

Kure Cells closed pre-Series A funding round led by Waed Ventures (Aramco) alongside NantBio, US93 and Qomel

rkjamvi@gmail.com
October 23, 2025

UF-Kure19 granted RMAT designation by FDA based on promising efficacy for LBCL and follicular lymphoma and rapid manufacturing

rkjamvi@gmail.com
October 17, 2025
Categories
KureCells
Follow us
w
We believe in open projects
View more

Disclaimer: Investigational products; safety and efficacy not yet established.

Privacy Policy

Expanded Access Policy

© 2025 kurecells, All Rights Reserved

Back to top Drag